THERE'S AN ALTERNATIVE TO WARFARIN
FOR PEOPLE WHO NEED ONE. IT'S CALLED WATCHMAN™.
A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.See How It Works
Explore our breakthrough products that make a meaningful difference in patient's lives.
Discover our reimbursement resources including coding guides and our c-code lookup tool.
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Boston Scientific Receives CE Mark for Vercise™ Gevia™ Deep Brain Stimulation System
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year
Boston Scientific Closes Symetis Acquisition
Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device
New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints
Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients
Boston Scientific Announces Schedule of Presentations at EuroPCR 2017
Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices